These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 15562137)

  • 41. Promoting transparency in pharmaceutical industry-sponsored research.
    Ross JS; Gross CP; Krumholz HM
    Am J Public Health; 2012 Jan; 102(1):72-80. PubMed ID: 22095335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medical research has 'black hole': negative results often fail to get published in journals; some blame drug industry.
    Hensley S; Abboud L
    Wall St J (East Ed); 2004 Jun; ():B3. PubMed ID: 15218882
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical researchers and pharmaceutical industry. Dangerous liaisons].
    Roos JC
    Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1668-71. PubMed ID: 10494304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Practical and political problems with a global research tax.
    Resnik DB
    Am J Bioeth; 2010 Jun; 10(6):44-5. PubMed ID: 20526971
    [No Abstract]   [Full Text] [Related]  

  • 45. Access to data from clinical trials sponsored by pharmaceutical companies.
    West R
    Addiction; 2007 May; 102(5):682-3. PubMed ID: 17493100
    [No Abstract]   [Full Text] [Related]  

  • 46. An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry.
    Winther FO; Hole OP; Nitter-Hauge S
    Eur J Clin Pharmacol; 2007 Oct; 63(10):909-12. PubMed ID: 17673994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corporate influence over clinical research: considering the alternatives.
    Prescrire Int; 2012 Jul; 21(129):191-4. PubMed ID: 22852295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
    Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK
    J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Managing financial conflicts of interest.
    IRB; 2003; 25(1):7. PubMed ID: 12833898
    [No Abstract]   [Full Text] [Related]  

  • 50. [For and against: does sponsoring impede the growth of knowledge in medicine?].
    Finzen A; Fritze J
    Psychiatr Prax; 2007 May; 34(4):162-4. PubMed ID: 17520527
    [No Abstract]   [Full Text] [Related]  

  • 51. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
    Newcombe JP; Kerridge IH
    Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. America's other drug problem: how the drug industry distorts medicine and politics.
    Relman AS; Angell M
    New Repub; 2002 Dec; 227(25):27-41. PubMed ID: 12561803
    [No Abstract]   [Full Text] [Related]  

  • 53. Medical ethics, research and the pharmaceutical industry.
    Abud-Mendoza C
    Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694
    [No Abstract]   [Full Text] [Related]  

  • 54. Participation of life-science faculty in research relationships with industry.
    Blumenthal D; Campbell EG; Causino N; Louis KS
    N Engl J Med; 1996 Dec; 335(23):1734-9. PubMed ID: 8929266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration.
    Vitiello B; Heiligenstein JH; Riddle MA; Greenhill LL; Fegert JM
    Biol Psychiatry; 2004 Jul; 56(1):3-9. PubMed ID: 15219466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is research presented at the scoliosis research society annual meeting influenced by industry funding?
    Roach JW; Skaggs DL; Sponseller PD; Macleod LM
    Spine (Phila Pa 1976); 2008 Sep; 33(20):2208-12. PubMed ID: 18725871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Open access publishing in the biomedical sciences: could funding agencies accelerate the inevitable changes?
    Glover SW; Webb A; Gleghorn C
    Health Info Libr J; 2006 Sep; 23(3):197-202. PubMed ID: 16911126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ghost story: at medical journals, writers paid by industry play big role.
    Mathews AW
    Wall St J (East Ed); 2005 Dec; ():A1, A8. PubMed ID: 16506304
    [No Abstract]   [Full Text] [Related]  

  • 59. Truly independent research?
    Lenzer J
    BMJ; 2008 Aug; 337():a1332. PubMed ID: 18719008
    [No Abstract]   [Full Text] [Related]  

  • 60. Industry-funded positive studies not associated with better design or larger size.
    Cunningham MR; Warme WJ; Schaad DC; Wolf FM; Leopold SS
    Clin Orthop Relat Res; 2007 Apr; 457():235-41. PubMed ID: 17195818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.